Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD
Public ClinicalTrials.gov record NCT03805100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane Versus Lucentis® in Patients With Neovascular Age-Related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of the study are to demonstrate the equivalence of Xlucane to Lucentis® in treatment of subjects with wet (ie, neovascular) age-related macular degeneration (wAMD).
Study identification
- NCT ID
- NCT03805100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 582 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 19, 2019 (Actual)
- Primary completion
- May 11, 2021 (Actual)
- Completion
- Nov 11, 2021 (Actual)
- Last update posted
- Nov 13, 2023
2019 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 11
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute, LLC | Gilbert | Arizona | 85296 | — |
| Arizona Retina and Vitreous Consultants | Phoenix | Arizona | 85021-8880 | — |
| Retina Centers P.C | Tucson | Arizona | 85704-5611 | — |
| Win Retina | Arcadia | California | 91006-3607 | — |
| The Retina Partners | Encino | California | 91436-2018 | — |
| Mark B. Kislinger MD Inc. | Glendora | California | 91741 | — |
| Retina Consultants Medical Group Inc. | Sacramento | California | 95819 | — |
| Colorado Retina Associates | Golden | Colorado | 80401-5069 | — |
| Fort Lauderdale Eye Institute | Fort Lauderdale | Florida | 33324-3118 | — |
| Sarasota Retina Institute | Sarasota | Florida | 34239-7246 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880-3919 | — |
| Southeast Retina Center | Augusta | Georgia | 30909-6440 | — |
| Georgia Retina | Marietta | Georgia | 30060 | — |
| Gailey Eye Clinic | Bloomington | Illinois | 61704 | — |
| Sabates Eye Centers | Leawood | Kansas | 66211 | — |
| Retina Vitreous Surgeons of Central New York PC | New York | New York | 13224 | — |
| Retina Associates of Western New York | Rochester | New York | 14620-4655 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29456 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Austin Retina Associates | Austin | Texas | 78705-1169 | — |
| Houston Eye Associates | Houston | Texas | 77025-1756 | — |
| Retina Consultants of Houston | Houston | Texas | 77030-2727 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240-1502 | — |
| Retina Consultants of Houston | The Woodlands | Texas | 77384 | — |
| Strategic Clinical Research Group LLC | Willow Park | Texas | 76087 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03805100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2023 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03805100 live on ClinicalTrials.gov.